Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Cyclically Adjusted Book per Share: ¥3.17 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600381 Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
64 GF Score
Price ¥4.20
GF Value ¥5.85
Valuation Modestly Undervalued
View Full Analysis

What is Qinghai Spring Medicinal Resources Technology Co Cyclically Adjusted Book per Share?

Qinghai Spring Medicinal Resources Technology Co SHSE:600381 -1.64% 64 Cyclically Adjusted Book per Share is ¥3.17 as of Mar. 2026. GuruFocus rates SHSE:600381 with a GF Score™ of 64/100 and a GF Value™ of ¥5.85 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Qinghai Spring Medicinal Resources Technology Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥1.668. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.17 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Qinghai Spring Medicinal Resources Technology Co's average Cyclically Adjusted Book Growth Rate was -2.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -1.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Qinghai Spring Medicinal Resources Technology Co was 57.60% per year. The lowest was -15.80% per year. And the median was 2.50% per year.

As of today (2026-07-19), Qinghai Spring Medicinal Resources Technology Co's current stock price is ¥4.20. Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥3.17. Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted PB Ratio of today is 1.32.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Qinghai Spring Medicinal Resources Technology Co was 28.28. The lowest was 0.59. And the median was 2.33.


Qinghai Spring Medicinal Resources Technology Co  (SHSE:600381) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.20/3.17
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Qinghai Spring Medicinal Resources Technology Co was 28.28. The lowest was 0.59. And the median was 2.33.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Qinghai Spring Medicinal Resources Technology Co Cyclically Adjusted Book per Share Related Terms


Qinghai Spring Medicinal Resources Technology Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qinghai Spring Medicinal Resources Technology Co Cyclically Adjusted Book per Share Chart

Qinghai Spring Medicinal Resources Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.50 3.21 3.32 3.25 3.19

Qinghai Spring Medicinal Resources Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 3.22 3.21 3.19 3.17

SHSE:600381 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qinghai Spring Medicinal Resources Technology Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600381
64GF Score
Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qinghai Spring Medicinal Resources Technology Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Qinghai Spring Medicinal Resources Technology Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.668/116.3033*116.3033
=1.668

Current CPI (Mar. 2026) = 116.3033.

Qinghai Spring Medicinal Resources Technology Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.628 101.400 3.014
201609 2.688 102.400 3.053
201612 2.917 102.600 3.307
201703 2.972 103.200 3.349
201706 3.040 103.100 3.429
201709 3.470 104.100 3.877
201712 3.671 104.500 4.086
201803 3.733 105.300 4.123
201806 3.796 104.900 4.209
201809 4.040 106.600 4.408
201812 4.047 106.500 4.420
201903 4.067 107.700 4.392
201906 4.059 107.700 4.383
201909 4.011 109.800 4.249
201912 4.069 111.200 4.256
202003 4.038 112.300 4.182
202006 3.959 110.400 4.171
202009 3.893 111.700 4.053
202012 3.524 111.500 3.676
202103 3.509 112.662 3.622
202106 3.440 111.769 3.580
202109 3.422 112.215 3.547
202112 3.101 113.108 3.189
202203 3.061 114.335 3.114
202206 3.018 114.558 3.064
202209 2.973 115.339 2.998
202212 2.611 115.116 2.638
202303 2.562 115.116 2.588
202306 2.525 114.558 2.563
202309 2.491 115.339 2.512
202312 2.155 114.781 2.184
202403 2.109 115.227 2.129
202406 2.031 114.781 2.058
202409 1.943 115.785 1.952
202412 1.759 114.893 1.781
202503 1.774 115.116 1.792
202506 1.761 114.907 1.782
202509 1.754 115.471 1.767
202512 1.695 115.832 1.702
202603 1.668 116.303 1.668

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥3.17 mean?
Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) has a Cyclically Adjusted Book per Share of ¥3.17 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors.
Is Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted Book per Share too high?
Qinghai Spring Medicinal Resources Technology Co's current Cyclically Adjusted Book per Share is ¥3.17. Overall, Qinghai Spring Medicinal Resources Technology Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Qinghai Spring Medicinal Resources Technology Co's Cyclically Adjusted Book per Share of ¥3.17 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors. Qinghai Spring Medicinal Resources Technology Co's current Cyclically Adjusted Book per Share is ¥3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qinghai Spring Medicinal Resources Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.85, compared to a current price of ¥4.20 — trading 28.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥3.17. Qinghai Spring Medicinal Resources Technology Co's overall GF Score™ is 64/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Qinghai Spring Medicinal Resources Technology Co (SHSE:600381), the current Cyclically Adjusted Book per Share is ¥3.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Overvalued in 2026?

Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co stock appears to be undervalued. The current stock price of ¥4.20 is trading 28.2% below its estimated GF Value™ of ¥5.85. GuruFocus considers Qinghai Spring Medicinal Resources Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600381:

  • Cyclically Adjusted Book per Share: ¥3.17
  • GF Value™: ¥5.85 vs. price of ¥4.20 (28.2% below fair value)
  • GF Score™: 64/100

No single metric tells the full story. See the SHSE:600381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Qinghai Spring Medicinal Resources Technology Co Business Description

Address East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
64GF Score

Get the complete analysis for SHSE:600381

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.20
Price
¥5.85
GF Value